TY  - JOUR

T1  - Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer

JO  - Supportive Care in Cancer

PY  - 2015/10/19

AU  - Stopeck AT

AU  - Fizazi K

AU  - Body J-J

AU  - Brown JE

AU  - Carducci M

AU  - Diel I

AU  - Fujiwara Y

AU  - Martín M

AU  - Paterson A

AU  - Tonkin K

AU  - Shore N et al

ED  - 

DO  - DOI: 10.1007/s00520-015-2985-1

PB  - Springer Science and Business Media LLC

VL  - 24

IS  - 1

SP  - 457

EP  - 458

Y2  - 2024/12/21

ER  -